Quent Capital’s Opko Health OPK Stock Holding History

Quent Capital’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,500	Closed	-$5K	–	1272
2022 Q1	$5K	Buy	+1,500	New	+$5.3K	﹤0.01%	1054

Other funds holding OPK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Quent Capital's OPK Position: Q2 2022 in Review

Quent Capital sold out of Opko Health (OPK) in Q2 2022, closing a stake of 1,500 shares — an estimated $5K sold.

Quent Capital first reported a position in OPK in Q1 2022 and held it in 1 quarter. The position peaked at $5K in Q1 2022. 231 funds tracked by Wall St. Rank hold OPK as of Q2 2022.

Quent Capital reported no remaining Opko Health position as of Q2 2022 after selling out during the quarter.
Quent Capital sold 1,500 Opko Health shares in Q2 2022, an estimated $5K.
Quent Capital first reported a position in Opko Health in Q1 2022 and held it in 1 quarter.
Quent Capital's Opko Health position peaked at $5K in Q1 2022.
231 funds tracked by Wall St. Rank held Opko Health as of Q2 2022.

Based on Quent Capital's 13F filing for Q2 2022, filed 8 Aug 2022.